Literature DB >> 620402

In vitro plasminogen activator activity in human brain tumors.

W S Tucker, W M Kirsch, A Martinez-Hernandez, L M Fink.   

Abstract

Cell cultures were prepared from nine human brain tumors. Fibrin plate assays showed plasminogen-dependent fibrinolytic activity in lysates and in material released by these neoplastic cells but not in those from normal adult human white matter. Antibodies against human urokinase caused catalytic inhibition of the urokinase and of the plasminogen activator from WI-38 cells, simian virus 40-transformed WI-38 cells, human prostatic cells, and human ovarian carcinoma cells. However, the anti-urokinase immunoglobulin G did not inhibit the plasminogen activator activity of any of the human brain tumor preparations. These studies indicate that the plasminogen activator produced by human brain tumor cells is antigenically different from the plasminogen activator of other human normal and neoplastic cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 620402

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Plasminogen activator secretion by granule neurons in cultures of developing cerebellum.

Authors:  A Krystosek; N W Seeds
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

2.  Immunological analysis of plasminogen activators from cultured human cancer cells.

Authors:  S Naito; K Sueishi; F Hattori; K Tanaka
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

3.  Establishment of a human renal pelvic cancer cell line producing tissue thromboplastin and plasminogen activator.

Authors:  S Naito; K Tanaka; T Kanamori; S Hisano; S Momose
Journal:  Urol Res       Date:  1982-02

4.  A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues.

Authors:  I Eto; M D Bandy
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

5.  Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.

Authors:  J S Rao; A Rayford; R A Morantz; B W Festoff; R Sawaya
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

6.  Protease-activated "prodrugs" for cancer chemotherapy.

Authors:  P L Carl; P K Chakravarty; J A Katzenellenbogen; M J Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

7.  Prognostic role of urokinase-type plasminogen activator in human gliomas.

Authors:  D W Hsu; J T Efird; E T Hedley-Whyte
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

Review 8.  Thromboembolic complications associated with brain tumors.

Authors:  R E Sawaya; B L Ligon
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells.

Authors:  E L Wilson; G E Francis
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Interrelationship between differentiation and malignancy-associated properties in glioma.

Authors:  M C Frame; R I Freshney; P F Vaughan; D I Graham; R Shaw
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.